RGD Reference Report - Epidermal Growth Factor Receptor-Responsive Indoleamine 2,3-Dioxygenase Confers Immune Homeostasis During Shigella flexneri Infection. - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

Epidermal Growth Factor Receptor-Responsive Indoleamine 2,3-Dioxygenase Confers Immune Homeostasis During Shigella flexneri Infection.

Authors: Mukherjee, Tanushree  Udupa, Vibha A V  Prakhar, Praveen  Chandra, Kasturi  Chakravortty, Dipshikha  Balaji, Kithiganahalli N 
Citation: Mukherjee T, etal., J Infect Dis. 2019 May 5;219(11):1841-1851. doi: 10.1093/infdis/jiz009.
RGD ID: 39938959
Pubmed: PMID:30615126   (View Abstract at PubMed)
DOI: DOI:10.1093/infdis/jiz009   (Journal Full-text)

The resolution of Shigella flexneri infection-associated hyperinflammation is crucial for host survival. Using in vitro and in vivo models of shigellosis, we found that S. flexneri induces the expression of indoleamine 2,3-dioxygenase 1 (IDO1) through the nucleotide oligomerization domain 2 (NOD2) and epidermal growth factor receptor (EGFR) signaling pathway. Congruently, abrogation of NOD2 or EGFR compromises the ability of S. flexneri to induce IDO1 expression. We observed that the loss of IDO1 function in vivo exacerbates shigellosis by skewing the inflammatory cytokine response, disrupting colon epithelial barrier integrity and consequently limiting the host life-span. Interestingly, administration of recombinant EGF rescued mice from IDO1 inhibition-driven aggravated shigellosis by restoring the cytokine balance and subsequently restricting bacterial growth. This is the first study that underscores the direct implication of the NOD2-EGFR axis in IDO1 production and its crucial homeostatic contributions during shigellosis. Together, these findings reveal EGF as a potential therapeutic intervention for infectious diseases.



RGD Manual Disease Annotations    Click to see Annotation Detail View

  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
EGFHumanshigellosis treatmentISOEgf (Mus musculus) RGD 
EgfMouseshigellosis treatmentIDA  RGD 
EgfRatshigellosis treatmentISOEgf (Mus musculus) RGD 
IDO1Humanshigellosis treatmentISOIdo1 (Mus musculus) RGD 
IL10Humanshigellosis treatmentISOIl10 (Mus musculus) RGD 
IL12BHumanshigellosis treatmentISOIl12b (Mus musculus) RGD 
IL1BHumanshigellosis treatmentISOIl1b (Mus musculus) RGD 
Ido1Mouseshigellosis treatmentIDA  RGD 
Ido1Ratshigellosis treatmentISOIdo1 (Mus musculus) RGD 
Il10Ratshigellosis treatmentISOIl10 (Mus musculus) RGD 
Il10Mouseshigellosis treatmentIEP  RGD 
Il12bRatshigellosis treatmentISOIl12b (Mus musculus) RGD 
Il12bMouseshigellosis treatmentIEP  RGD 
Il1bRatshigellosis treatmentISOIl1b (Mus musculus) RGD 
Il1bMouseshigellosis treatmentIEP  RGD 

Gene-Chemical Interaction Annotations    Click to see Annotation Detail View

  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
EGFHumanmuramyl dipeptide increases expression ISOEgf (Mus musculus)muramyl dipeptide increases expression of Egf mRNA in splenocytesRGD 
EgfRatmuramyl dipeptide increases expression ISOEgf (Mus musculus)muramyl dipeptide increases expression of Egf mRNA in splenocytesRGD 
EgfMousemuramyl dipeptide increases expression EXP muramyl dipeptide increases expression of Egf mRNA in splenocytesRGD 
IDO1Humanmuramyl dipeptide increases expressionISOIdo1 (Mus musculus)muramyl dipeptide increases expression of Ido1 mRNA in peritoneal macrophages and splenocytesRGD 
Ido1Ratmuramyl dipeptide increases expressionISOIdo1 (Mus musculus)muramyl dipeptide increases expression of Ido1 mRNA in peritoneal macrophages and splenocytesRGD 
Ido1Mousemuramyl dipeptide increases expressionEXP muramyl dipeptide increases expression of Ido1 mRNA in peritoneal macrophages and splenocytesRGD 

Objects Annotated

Genes (Rattus norvegicus)
Egf  (epidermal growth factor)
Ido1  (indoleamine 2,3-dioxygenase 1)
Il10  (interleukin 10)
Il12b  (interleukin 12B)
Il1b  (interleukin 1 beta)

Genes (Mus musculus)
Egf  (epidermal growth factor)
Ido1  (indoleamine 2,3-dioxygenase 1)
Il10  (interleukin 10)
Il12b  (interleukin 12b)
Il1b  (interleukin 1 beta)

Genes (Homo sapiens)
EGF  (epidermal growth factor)
IDO1  (indoleamine 2,3-dioxygenase 1)
IL10  (interleukin 10)
IL12B  (interleukin 12B)
IL1B  (interleukin 1 beta)


Additional Information